(Allergan plc)

	AGN latest price $185.3615 (-2.61%) ($185.2030 - $191.6016) on Wed. Oct. 10, 2018.
	Trend Analysis and Forecast
Average Daily Percentage Swing	1.01% (three month average)
RSI	39
Latest Price	$185.3615(-2.61%)
Stocks Behave Similarly	Similar Stock List
Daily Trend	AGN declines -0.7% a day on average for past five trading days.
Market Behavior	Broad based sell-off for large cap. Broad based sell-off for small cap.
Correlated ETFs	Broad market will support AGN advance at 0% a week (0% probability)   IBB(51%)    XBI(48%)    XLV(48%)    ARKG(47%)    IVW(46%)
Factors Impacting AGN price	AGN will decline at least -0.505% in a week (0% probabilities).   VIXM(-28%)    TLT(-23%)    UUP(-19%)    VXX(-15%)    DIA(-12%)
Relative Volatility	(options are extremely cheap)
Market Trend Strength	-0.505% (StdDev 1.01%)
Hourly BBV	0 ()
Intraday Trend	-3%

Resistance Level	$188.15
5 Day Moving Average	$188.38(-1.6%)
10 Day Moving Average	$189.25(-2.05%)
20 Day Moving Average	$188.15(-1.48%)
To recent high	-3.3%
To recent low	9.4%
Market Cap	$61.114b

Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1984 and is headquartered in Dublin, Ireland.

getNextHourMoveProbability failed